Presentation ESC 2022 Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease: Primary Results of the FOURIER-OLE (Open-Label Extension) Studies Presenter: Michelle L. O’Donoghue August 29, 2022
Presentation ESC 2022 Colchicine and Aspirin in Community Patients with COVID-19: An Open-label, Factorial, Randomized Trial Presenter: John Eikelboom August 29, 2022
Presentation ESC 2022 Colchicine and Rivaroxaban Plus Aspirin in Patients Hospitalized with COVID-19: A Factorial, Randomized, Open Trial Presenter: Sanjit Jolly August 28, 2022
Presentation Interventional Complications 2022 No Reflow: How to Avoid and When it Occurs, How to Manage Drugs Doses and Delivery Presenter: Rhian E. Davies July 16, 2022
Presentation EuroPCR 2022 Patient-Level Pooled Analysis of Ultrasound RDN in RADIANCE-HTN SOLO and TRIO Presenter: Ajay J. Kirtane, Michel Azizi May 17, 2022
Presentation ARCH 2022 Update on Pharmacology in the Cath Lab Presenter: James B. Hermiller April 23, 2022
Presentation ARCH 2022 Current Status and Future of Renal Denervation for Hypertension Presenter: Tim A. Fischell April 23, 2022
Presentation ACC 2022 The PACMAN AMI Randomized Clinical Trial Presenter: Lorenz Räber April 04, 2022
Presentation ACC 2022 Long Term Efficacy and Safety of Renal Denervation on Blood Pressure in Patients on Antihypertension Medications: 3-Year Outcomes from the SPYRAL HTN-ON MED Trial Presenter: Felix Mahfoud April 04, 2022
Presentation ACC 2022 Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial Presenter: Duk-Woo Park April 04, 2022
Presentation ACC 2022 A Single Ascending Dose Study of an siRNA Targeting Lipoprotein(a) Presenter: Steven E. Nissen April 04, 2022